Barclays
HCAT icon

Barclays’s Health Catalyst HCAT Stock Holding History

Barclays’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196K Buy
98,651
+32,512
+49% +$46.9K ﹤0.01% 3727
2026
Q1 		$84K Sell
66,139
-82,047
-55% -$154K ﹤0.01% 4100
2025
Q4 		$354K Buy
148,186
+10,100
+7% +$27.6K ﹤0.01% 4047
2025
Q3 		$394K Sell
138,086
-17,915
-11% -$61.3K ﹤0.01% 3952
2025
Q2 		$588K Sell
156,001
-109,352
-41% -$430K ﹤0.01% 3669
2025
Q1 		$1.2M Buy
265,353
+90,546
+52% +$479K ﹤0.01% 2998
2024
Q4 		$1.24M Buy
174,807
+14,656
+9% +$117K ﹤0.01% 3232
2024
Q3 		$1.3M Buy
160,151
+56,369
+54% +$407K ﹤0.01% 3177
2024
Q2 		$663K Sell
103,782
-721
-0.7% -$4.63K ﹤0.01% 2855
2024
Q1 		$787K Sell
104,503
-23,522
-18% -$215K ﹤0.01% 3303
2023
Q4 		$1.19M Buy
128,025
+74,816
+141% +$611K ﹤0.01% 3310
2023
Q3 		$538K Buy
53,209
+30,580
+135% +$365K ﹤0.01% 2760
2023
Q2 		$283K Sell
22,629
-6,570
-23% -$78.2K ﹤0.01% 3080
2023
Q1 		$341K Buy
29,199
+12,729
+77% +$162K ﹤0.01% 3511
2022
Q4 		$175K Buy
16,470
+12,054
+273% +$116K ﹤0.01% 3911
2022
Q3 		$43K Sell
4,416
-20,071
-82% -$266K ﹤0.01% 3823
2022
Q2 		$354K Buy
24,487
+4,582
+23% +$78.1K ﹤0.01% 3093
2022
Q1 		$521K Buy
+19,905
New +$565K ﹤0.01% 2874

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's HCAT Position: Q2 2026 in Review

Barclays increased its Health Catalyst (HCAT) stake by 49% in Q2 2026, buying an estimated $46.9K and bringing the position to 98,651 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #3727.

Barclays first reported a position in HCAT in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.3M in Q3 2024. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Barclays held 98,651 shares of Health Catalyst worth $196K as of Q2 2026.
  • Barclays bought 32,512 Health Catalyst shares in Q2 2026, an estimated $46.9K.
  • Health Catalyst made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3727 holding.
  • Barclays first reported a position in Health Catalyst in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Health Catalyst position peaked at $1.3M in Q3 2024.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.